2023-2029 Global Meglinitide Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 150 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Meglinitide should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Meglinitide market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Meglinitide market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Repaglinide segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Type II Diabetes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Meglinitide include Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., Bristol Myers Squibb Company and GSK Plc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Meglinitides are the agents used to treat type 2 diabetes. They act same as β-cell receptor as sulphonylureas, but have a different chemical structure. They are novel class of non-sulfonylurea insulin secretagogues characterized by very rapid onset and abbreviated duration of action. They act by stimulating pancreas to release insulin in response to meal. In functioning pancreatic beta cells, it also closes ATP-dependent potassium dependent channels. Due to this depolarization of beta cells, opening of calcium channels resulting in influx of calcium and Increased intracellular calcium induces insulin secretion.
This report aims to provide a comprehensive study of the global market for Meglinitide. Report Highlights:
(1) Global Meglinitide market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Meglinitide market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Meglinitide market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Meglinitide segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Meglinitide segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Meglinitide, capacity, production and trends.
(7) Meglinitide industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Repaglinide
Nateglinide
Other
Market segment by application, can be divided into
Type II Diabetes
Others
Market segment by players, this report covers
Pfizer Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Novartis AG
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
GSK Plc
Bayer AG
Sun Pharmaceutical Industries Ltd
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma

1 Market Overview
1.1 Meglinitide Definition
1.2 Global Meglinitide Market Size and Forecast
1.2.1 By Revenue, Global Meglinitide Market Size, 2018-2029
1.2.2 By Sales Volume, Global Meglinitide Market Size, 2018-2029
1.2.3 Global Meglinitide Price Trend, 2018-2029
1.3 China Meglinitide Market Size and Forecast
1.3.1 By Revenue, China Meglinitide Market Size, 2018-2029
1.3.2 By Sales Volume, China Meglinitide Market Size, 2018-2029
1.3.3 China Meglinitide Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Meglinitide Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Meglinitide Share in Global Market, 2018-2029
1.4.3 Meglinitide Market Size: China VS Global, 2018-2029
1.5 Meglinitide Market Dynamics
1.5.1 Meglinitide Market Drivers
1.5.2 Meglinitide Market Restraints
1.5.3 Meglinitide Industry Trends
1.5.4 Meglinitide Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Meglinitide Revenue by Company, 2018-2023
2.2 Global Meglinitide Sales Volume by Company, 2018-2023
2.3 Global Meglinitide Price by Company, 2018-2023
2.4 Global Meglinitide Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Meglinitide Concentration Ratio
2.6 Global Meglinitide Mergers & Acquisitions, Expansion Plans
2.7 Global Meglinitide Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Meglinitide Revenue by Company, 2018-2023
3.2 China Meglinitide Sales Volume by Company, 2018-2023
3.3 China Meglinitide Meglinitide Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Meglinitide Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Meglinitide Domestic VS Export
3.6 China Market, Meglinitide Import & Export
3.6.1 China Market, Meglinitide Import & Export, 2018-2029
3.6.2 China Meglinitide Import & Export Trends
3.6.3 Main Sources of China Meglinitide Import
3.6.4 Export Destination of China Meglinitide
4 Meglinitide Production by Region
4.1 Global Meglinitide Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Meglinitide Manufacturers
4.3 Global Major Manufacturers, Meglinitide Capacity Expansion and Future Plans
4.4 Global Meglinitide Capacity by Region
4.5 Global Meglinitide Production by Region
4.5.1 Global Meglinitide Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Meglinitide Production by Region, 2018-2023
4.5.3 Global Meglinitide Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Meglinitide Industry Chain
5.2 Meglinitide Upstream Analysis
5.2.1 Meglinitide Core Raw Materials
5.2.2 Main Manufacturers of Meglinitide Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Meglinitide Production Mode
5.6 Meglinitide Procurement Model
5.7 Meglinitide Industry Sales Model and Sales Channels
5.7.1 Meglinitide Sales Model
5.7.2 Meglinitide Typical Distributors
6 Sights by Type
6.1 Meglinitide Classification
6.1.1 Repaglinide
6.1.2 Nateglinide
6.1.3 Other
6.2 By Type, Global Meglinitide Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Meglinitide Revenue, 2018-2029
6.4 By Type, Global Meglinitide Sales Volume, 2018-2029
6.5 By Type, Global Meglinitide Price, 2018-2029
7 Sights by Application
7.1 Meglinitide Segment by Application
7.1.1 Type II Diabetes
7.1.2 Others
7.2 By Application, Global Meglinitide Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Meglinitide Revenue, 2018-2029
7.4 By Application, Global Meglinitide Sales Volume, 2018-2029
7.5 By Application, Global Meglinitide Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Meglinitide Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Meglinitide Revenue, 2018-2029
8.3 By Region, Global Meglinitide Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Meglinitide Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Meglinitide Market Size Market Share
8.5 Europe
8.5.1 Europe Meglinitide Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Meglinitide Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Meglinitide Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Meglinitide Market Size Market Share
8.7 South America
8.7.1 South America Meglinitide Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Meglinitide Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Meglinitide Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Meglinitide Revenue, 2018-2029
9.3 By Country, Global Meglinitide Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Meglinitide Market Size, 2018-2029
9.4.2 By Company, U.S. Meglinitide Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Meglinitide Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Meglinitide Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Meglinitide Market Size, 2018-2029
9.5.2 By Company, Europe Meglinitide Sales Volume Market Share, 2022
9.5.3 By Type, Europe Meglinitide Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Meglinitide Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Meglinitide Market Size, 2018-2029
9.6.2 By Company, China Meglinitide Sales Volume Market Share, 2022
9.6.3 By Type, China Meglinitide Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Meglinitide Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Meglinitide Market Size, 2018-2029
9.7.2 By Company, Japan Meglinitide Sales Volume Market Share, 2022
9.7.3 By Type, Japan Meglinitide Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Meglinitide Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Meglinitide Market Size, 2018-2029
9.8.2 By Company, South Korea Meglinitide Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Meglinitide Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Meglinitide Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Meglinitide Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Meglinitide Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Meglinitide Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Meglinitide Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Meglinitide Market Size, 2018-2029
9.10.2 By Company, India Meglinitide Sales Volume Market Share, 2022
9.10.3 By Type, India Meglinitide Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Meglinitide Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Meglinitide Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Meglinitide Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Meglinitide Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Meglinitide Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Inc Meglinitide Models, Specifications and Application
10.1.3 Pfizer Inc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Inc Company Profile and Main Business
10.1.5 Pfizer Inc Recent Developments
10.2 F. Hoffmann-La Roche Ltd
10.2.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 F. Hoffmann-La Roche Ltd Meglinitide Models, Specifications and Application
10.2.3 F. Hoffmann-La Roche Ltd Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.2.5 F. Hoffmann-La Roche Ltd Recent Developments
10.3 Mylan N.V
10.3.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan N.V Meglinitide Models, Specifications and Application
10.3.3 Mylan N.V Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Mylan N.V Company Profile and Main Business
10.3.5 Mylan N.V Recent Developments
10.4 Fresenius Kabi AG
10.4.1 Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
10.4.2 Fresenius Kabi AG Meglinitide Models, Specifications and Application
10.4.3 Fresenius Kabi AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Fresenius Kabi AG Company Profile and Main Business
10.4.5 Fresenius Kabi AG Recent Developments
10.5 Hikma Pharmaceuticals PLC
10.5.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.5.2 Hikma Pharmaceuticals PLC Meglinitide Models, Specifications and Application
10.5.3 Hikma Pharmaceuticals PLC Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.5.5 Hikma Pharmaceuticals PLC Recent Developments
10.6 Novartis AG
10.6.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.6.2 Novartis AG Meglinitide Models, Specifications and Application
10.6.3 Novartis AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Novartis AG Company Profile and Main Business
10.6.5 Novartis AG Recent Developments
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.7.2 Teva Pharmaceutical Industries Ltd. Meglinitide Models, Specifications and Application
10.7.3 Teva Pharmaceutical Industries Ltd. Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.8 Bristol Myers Squibb Company
10.8.1 Bristol Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.8.2 Bristol Myers Squibb Company Meglinitide Models, Specifications and Application
10.8.3 Bristol Myers Squibb Company Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bristol Myers Squibb Company Company Profile and Main Business
10.8.5 Bristol Myers Squibb Company Recent Developments
10.9 GSK Plc
10.9.1 GSK Plc Company Information, Head Office, Market Area and Industry Position
10.9.2 GSK Plc Meglinitide Models, Specifications and Application
10.9.3 GSK Plc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK Plc Company Profile and Main Business
10.9.5 GSK Plc Recent Developments
10.10 Bayer AG
10.10.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.10.2 Bayer AG Meglinitide Models, Specifications and Application
10.10.3 Bayer AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Bayer AG Company Profile and Main Business
10.10.5 Bayer AG Recent Developments
10.11 Sun Pharmaceutical Industries Ltd
10.11.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.11.2 Sun Pharmaceutical Industries Ltd Meglinitide Models, Specifications and Application
10.11.3 Sun Pharmaceutical Industries Ltd Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.12 Novartis AG
10.12.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.12.2 Novartis AG Meglinitide Models, Specifications and Application
10.12.3 Novartis AG Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Novartis AG Company Profile and Main Business
10.12.5 Novartis AG Recent Developments
10.13 Lupin
10.13.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.13.2 Lupin Meglinitide Models, Specifications and Application
10.13.3 Lupin Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Lupin Company Profile and Main Business
10.13.5 Lupin Recent Developments
10.14 Cipla Inc
10.14.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Cipla Inc Meglinitide Models, Specifications and Application
10.14.3 Cipla Inc Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Cipla Inc Company Profile and Main Business
10.14.5 Cipla Inc Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.15.2 Aurobindo Pharma Meglinitide Models, Specifications and Application
10.15.3 Aurobindo Pharma Meglinitide Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Meglinitide Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Meglinitide Market Restraints
Table 3. Meglinitide Market Trends
Table 4. Meglinitide Industry Policy
Table 5. Global Meglinitide Revenue by Company, 2018-2023, US$ million
Table 6. Global Meglinitide Revenue Market Share by Company, 2018-2023
Table 7. Global Meglinitide Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Meglinitide Sales Volume Market Share by Company, 2018-2023
Table 9. Global Meglinitide Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Meglinitide Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Meglinitide Mergers & Acquisitions, Expansion Plans
Table 12. Global Meglinitide Manufacturers Product Type
Table 13. China Meglinitide Revenue by Company, 2018-2023, US$ million
Table 14. China Meglinitide Revenue Market Share by Company, 2018-2023
Table 15. China Meglinitide Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Meglinitide Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Meglinitide Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Meglinitide Import & Export Trends
Table 19. Main Sources of China Meglinitide Import
Table 20. Export Destination of China Meglinitide
Table 21. Global Headquarters and Manufacturing Base of Meglinitide Manufacturers
Table 22. Global Major Manufacturers, Meglinitide Capacity Expansion and Future Plans
Table 23. Global Meglinitide Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Meglinitide Production by Region, 2018-2023, (K Units)
Table 25. Global Meglinitide Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Meglinitide Upstream (Raw Materials)
Table 27. Global Meglinitide Typical Customers
Table 28. Meglinitide Typical Distributors
Table 29. By Type, Global Meglinitide Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Meglinitide Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Meglinitide Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Meglinitide Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Meglinitide Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Meglinitide Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Meglinitide Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Meglinitide Revenue Market Share, 2018-2029
Table 37. By Country, Global Meglinitide Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Meglinitide Sales Volume Market Share, 2018-2029
Table 39. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Inc Meglinitide Models, Specifications and Application
Table 41. Pfizer Inc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Inc Company Profile and Main Business
Table 43. Pfizer Inc Recent Developments
Table 44. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. F. Hoffmann-La Roche Ltd Meglinitide Models, Specifications and Application
Table 46. F. Hoffmann-La Roche Ltd Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 48. F. Hoffmann-La Roche Ltd Recent Developments
Table 49. Mylan N.V Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan N.V Meglinitide Models, Specifications and Application
Table 51. Mylan N.V Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Mylan N.V Company Profile and Main Business
Table 53. Mylan N.V Recent Developments
Table 54. Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
Table 55. Fresenius Kabi AG Meglinitide Models, Specifications and Application
Table 56. Fresenius Kabi AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Fresenius Kabi AG Company Profile and Main Business
Table 58. Fresenius Kabi AG Recent Developments
Table 59. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 60. Hikma Pharmaceuticals PLC Meglinitide Models, Specifications and Application
Table 61. Hikma Pharmaceuticals PLC Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 63. Hikma Pharmaceuticals PLC Recent Developments
Table 64. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 65. Novartis AG Meglinitide Models, Specifications and Application
Table 66. Novartis AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Novartis AG Company Profile and Main Business
Table 68. Novartis AG Recent Developments
Table 69. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 70. Teva Pharmaceutical Industries Ltd. Meglinitide Models, Specifications and Application
Table 71. Teva Pharmaceutical Industries Ltd. Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 73. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 74. Bristol Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 75. Bristol Myers Squibb Company Meglinitide Models, Specifications and Application
Table 76. Bristol Myers Squibb Company Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bristol Myers Squibb Company Company Profile and Main Business
Table 78. Bristol Myers Squibb Company Recent Developments
Table 79. GSK Plc Company Information, Head Office, Market Area and Industry Position
Table 80. GSK Plc Meglinitide Models, Specifications and Application
Table 81. GSK Plc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. GSK Plc Company Profile and Main Business
Table 83. GSK Plc Recent Developments
Table 84. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 85. Bayer AG Meglinitide Models, Specifications and Application
Table 86. Bayer AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bayer AG Company Profile and Main Business
Table 88. Bayer AG Recent Developments
Table 89. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 90. Sun Pharmaceutical Industries Ltd Meglinitide Models, Specifications and Application
Table 91. Sun Pharmaceutical Industries Ltd Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 93. Sun Pharmaceutical Industries Ltd Recent Developments
Table 94. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 95. Novartis AG Meglinitide Models, Specifications and Application
Table 96. Novartis AG Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Novartis AG Company Profile and Main Business
Table 98. Novartis AG Recent Developments
Table 99. Lupin Company Information, Head Office, Market Area and Industry Position
Table 100. Lupin Meglinitide Models, Specifications and Application
Table 101. Lupin Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Lupin Company Profile and Main Business
Table 103. Lupin Recent Developments
Table 104. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Cipla Inc Meglinitide Models, Specifications and Application
Table 106. Cipla Inc Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Cipla Inc Company Profile and Main Business
Table 108. Cipla Inc Recent Developments
Table 109. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 110. Aurobindo Pharma Meglinitide Models, Specifications and Application
Table 111. Aurobindo Pharma Meglinitide Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Aurobindo Pharma Company Profile and Main Business
Table 113. Aurobindo Pharma Recent Developments
List of Figure
Figure 1. Meglinitide Picture
Figure 2. By Revenue, Global Meglinitide Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Meglinitide Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Meglinitide Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Meglinitide Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Meglinitide Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Meglinitide Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Meglinitide Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Meglinitide Share of Global Market, 2018-2029
Figure 10. Global Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Meglinitide Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Meglinitide Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Meglinitide Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Meglinitide Domestic VS Export, 2022
Figure 16. Global Meglinitide Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Meglinitide Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Meglinitide Production Market Share & Forecast by Region, 2018-2029
Figure 19. Meglinitide Industry Chain
Figure 20. Meglinitide Procurement Model
Figure 21. Meglinitide Sales Model
Figure 22. Meglinitide Sales Channels, Direct Sales and Distribution
Figure 23. Repaglinide
Figure 24. Nateglinide
Figure 25. Other
Figure 26. By Type, Global Meglinitide Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Meglinitide Revenue Market Share, 2018-2029
Figure 28. By Type, Global Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Meglinitide Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Meglinitide Price, 2018-2029, (US$/Unit)
Figure 31. Type II Diabetes
Figure 32. Others
Figure 33. By Application, Global Meglinitide Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Meglinitide Revenue Market Share, 2018-2029
Figure 35. By Application, Global Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Meglinitide Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Meglinitide Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Meglinitide Revenue Market Share, 2018-2029
Figure 39. By Region, Global Meglinitide Sales Volume Market Share, 2018-2029
Figure 40. North America Meglinitide Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Meglinitide Revenue Market Share, 2022
Figure 42. Europe Meglinitide Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Meglinitide Revenue Market Share, 2022
Figure 44. Asia Pacific Meglinitide Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Meglinitide Revenue Market Share, 2022
Figure 46. South America Meglinitide Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Meglinitide Revenue Market Share, 2022
Figure 48. Middle East & Africa Meglinitide Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Meglinitide Market Share, 2022
Figure 51. By Type, U.S. Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Meglinitide Market Share, 2022
Figure 55. By Type, Europe Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 57. China Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Meglinitide Market Share, 2022
Figure 59. By Type, China Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Meglinitide Market Share, 2022
Figure 63. By Type, Japan Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Meglinitide Market Share, 2022
Figure 67. By Type, South Korea Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Meglinitide Market Share, 2022
Figure 71. By Type, Southeast Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 73. India Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Meglinitide Market Share, 2022
Figure 75. By Type, India Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Meglinitide Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Meglinitide Market Share, 2022
Figure 79. By Type, Middle East & Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Meglinitide Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets